Patient and practice factors associated with HbA1c testing frequency in patients with type 2 diabetes: a retrospective cohort study in Australian general practice.

IF 1.2 4区医学 Q4 HEALTH CARE SCIENCES & SERVICES

Australian journal of primary health Pub Date : 2023-10-01 DOI:10.1071/PY22026

Chisato 'Chrissy' Imai, Ling Li, Rae-Anne Hardie, Christopher Pearce, Andrew Georgiou

{"title":"Patient and practice factors associated with HbA1c testing frequency in patients with type 2 diabetes: a retrospective cohort study in Australian general practice.","authors":"Chisato 'Chrissy' Imai, Ling Li, Rae-Anne Hardie, Christopher Pearce, Andrew Georgiou","doi":"10.1071/PY22026","DOIUrl":null,"url":null,"abstract":"Background: Better adherence to guideline-recommended glycated haemoglobin A1c (HbA1c) testing frequency is associated with better glycaemic control and lower risk of complications such as chronic kidney disease in patients with type 2 diabetes. This study investigates patient and practice factors associated with adherence to guideline-recommended HbA1c testing frequency.Methods: A cohort of type 2 diabetes patients who regularly visited general practices from 2012 to 2018 was identified from 225 Australian general practices. With the goal of ≤53mmol/mol, Australian guidelines recommend HbA1c testing at least 6-monthly. Patient history of HbA1c tests from 2017 to 2018 was used to define adherence to guidelines, and the associations with patient and practice factors were examined by regression models.Results: Of the 6881 patients, 2186 patients (31.8%) had 6-monthly HbA1c testing. Patient age and anti-diabetic medications were associated with adherence to 6-monthly testing. When financial incentives are available to practices, a larger practice was associated with better adherence to 6-monthly testing.Conclusions: The identified key factors such as age, practice size, medication, and incentive payments can be used to target initiatives aimed at improving guideline-recommended monitoring care for patients with type 2 diabetes to enhance their health outcomes.","PeriodicalId":8651,"journal":{"name":"Australian journal of primary health","volume":" ","pages":"520-526"},"PeriodicalIF":1.2000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian journal of primary health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1071/PY22026","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Better adherence to guideline-recommended glycated haemoglobin A1c (HbA1c) testing frequency is associated with better glycaemic control and lower risk of complications such as chronic kidney disease in patients with type 2 diabetes. This study investigates patient and practice factors associated with adherence to guideline-recommended HbA1c testing frequency.

Methods: A cohort of type 2 diabetes patients who regularly visited general practices from 2012 to 2018 was identified from 225 Australian general practices. With the goal of ≤53mmol/mol, Australian guidelines recommend HbA1c testing at least 6-monthly. Patient history of HbA1c tests from 2017 to 2018 was used to define adherence to guidelines, and the associations with patient and practice factors were examined by regression models.

Results: Of the 6881 patients, 2186 patients (31.8%) had 6-monthly HbA1c testing. Patient age and anti-diabetic medications were associated with adherence to 6-monthly testing. When financial incentives are available to practices, a larger practice was associated with better adherence to 6-monthly testing.

Conclusions: The identified key factors such as age, practice size, medication, and incentive payments can be used to target initiatives aimed at improving guideline-recommended monitoring care for patients with type 2 diabetes to enhance their health outcomes.

查看原文本刊更多论文

与2型糖尿病患者HbA1c检测频率相关的患者和实践因素：澳大利亚全科医学的回顾性队列研究。

背景：更好地遵守指南推荐的糖化血红蛋白A1c（HbA1c）检测频率与2型糖尿病患者更好地控制血糖和降低并发症（如慢性肾脏疾病）的风险有关。本研究调查了与坚持指南推荐的HbA1c检测频率相关的患者和实践因素。方法：从225名澳大利亚全科医生中确定了一组2012年至2018年定期就诊的2型糖尿病患者。以≤53mmol/mol为目标，澳大利亚指南建议至少6个月进行HbA1c检测。2017年至2018年的HbA1c检测患者史用于确定对指南的遵守情况，并通过回归模型检验与患者和实践因素的相关性。结果：6881例患者中，2186例（31.8%）进行了6个月的HbA1c检测。患者年龄和抗糖尿病药物与坚持6个月的测试有关。当实践可以获得经济激励时，更大的实践与更好地坚持6个月的测试有关。结论：已确定的关键因素，如年龄、执业规模、药物和激励金，可用于针对旨在改善指南建议的2型糖尿病患者监测护理的举措，以提高他们的健康结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Australian journal of primary health 医学-公共卫生、环境卫生与职业卫生

CiteScore

2.20

自引率

15.40%

发文量

136

审稿时长

6-12 weeks

期刊介绍： Australian Journal of Primary Health integrates the theory and practise of community health services and primary health care. The journal publishes high-quality, peer-reviewed research, reviews, policy reports and analyses from around the world. Articles cover a range of issues influencing community health services and primary health care, particularly comprehensive primary health care research, evidence-based practice (excluding discipline-specific clinical interventions) and primary health care policy issues. Australian Journal of Primary Health is an important international resource for all individuals and organisations involved in the planning, provision or practise of primary health care. Australian Journal of Primary Health is published by CSIRO Publishing on behalf of La Trobe University.